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Abstract
Background—This study applied item response theory (IRT) and latent class analysis (LCA)
procedures to examine the dimensionality and heterogeneity of comorbid substance use disorders
(SUDs) and explored their utility for standard clinical assessments, including the Addiction
Severity Index (ASI), HIV Risk Behavior Scale (HRBS), and SF-36 quality-of-life measures.
Methods—The sample included 343 opioid-dependent patients enrolled in two national multisite
studies of the U.S. National Drug Abuse Treatment Clinical Trials Network (CTN001–002).
Patients were recruited from inpatient and outpatient addiction treatment settings at 12 programs.
Data were analyzed by factor analysis, IRT, LCA, and latent regression procedures.
*A Supplementary figure for this article can be found by accessing the online version at http://dx.doi.org by entering doi:……
© 2011 Elsevier Ireland Ltd. All rights reserved.
**Corresponding author: Li-Tzy Wu, Duke University School of Medicine, Department of Psychiatry and Behavioral Sciences, Duke
University Medical Center, Box 3419, Durham, NC 27710, USA; tel.: 919-668-6067; litzy.wu@duke.edu.
Contributors: Dr. Wu designed the research questions and wrote the initial draft. Drs. Wu, Burchett, Yang, Pan, and Reeve contributed
to the data analysis. All authors contributed to the interpretation of the data and revision of the paper. Dr. Ling was the principal
investigator of the original two trials.
Conflicts of Interest: Dr. Ling has received research funding from Titan Pharmaceuticals, Reckitt Benckiser, and Hythiam; he has
served as a member of the Advisory Board for the US World Meds. Dr. Woody is a member of the RADARS post-marketing study
external advisory group whose job is to assess abuse of prescription medications. Denver Health administers RADARS, and
pharmaceutical companies support its work. The other authors have no conflicts of interest to disclose.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
NIH Public Access
Author Manuscript
Drug Alcohol Depend. Author manuscript; available in PMC 2012 November 1.
Published in final edited form as:













Results—A two-class LCA model fit dichotomous SUD data empirically better than one-
parameter and two-parameter IRT models. LCA distinguished 10% of severe comorbid opioid-
dependent individuals who had high rates of all SUDs examined—especially amphetamine and
sedative abuse/dependence—from the remaining 90% who had SUDs other than amphetamine and
sedative abuse/dependence (entropy=0.99). Item-level results from both one-parameter and two-
parameter IRT models also found that amphetamine and sedative abuse/dependence tapped the
more severe end of the latent poly-SUD trait. Regardless of whether SUDs were defined as a
continuous trait or categorically, individuals characterized by a high level of poly-SUD
demonstrated more psychiatric problems and HIV risk behaviors.
Conclusions—A combined application of categorical and dimensional latent approaches may
improve the understanding of comorbid SUDs and their associations with other clinical indicators.
Abuse of sedatives and methamphetamine may serve as a useful marker for identifying subsets of
opioid-dependent individuals with needs for more intensive interventions.
Keywords
clinical trials network; comorbidity; item response theory; latent class analysis; multiple
indicators–multiple causes model; opioid dependence; polysubstance use; substance use disorders
1. Introduction
Opioid use disorders are among the most prevalent substance use disorders (SUDs) in
addiction treatment programs, and comorbid SUDs are widespread among patients with
opioid addiction (Strain, 2002; Substance Abuse and Mental Health Services Administration
[SAMHSA], 2009). Due to a significant increase in prescription opioid abuse, opioid use
disorders now comprise the second most prevalent drug use disorder in the United States
(following marijuana), and opioids are associated with the highest rate of increase in
addiction treatment use (SAMHSA, 2010). Evidence from the National Epidemiologic
Survey on Alcohol and Related Conditions confirms a higher lifetime rate of SUDs (alcohol,
nicotine, any drug) among heroin users (63–85%), other opioid users (53–76%), and heroin–
other opioid users (72–94%) than among non-opioid drug users (34–63%) (Wu et al., 2011).
Comorbid SUDs complicate clinical courses and treatment designs (Strain, 2002; Veilleux et
al., 2010). Although researchers have highlighted the significance of incorporating full
diagnostic configurations into treatment and research designs (Carroll and Rounsaville,
2002; Rounsaville et al., 2003), little is known about how to conceptualize and classify co-
occurrences of multiple SUDs and how to link this information with other clinical indicators
to inform research and the forthcoming fifth edition of the Diagnostic and Statistical
Manual of Mental Disorders (DSM-5) (Saunders et al., 2007). Here, we apply item response
theory (IRT) and latent class analyses (LCA) to examine co-occurring SUDs, employing
regression procedures to link empirically defined latent variables with standard assessments
of clinical severity indicators.
The IRT approach to SUDs recognizes variability in the risk and manifestations of the
addiction severity continuum (Kirisci et al., 2006; Vanyukov et al., 2009). It assumes that a
latent severity trait underlies response patterns of SUDs; severity refers to various degrees of
maladaptive substance use behaviors and consequences measured by DSM-IV SUD criteria.
This approach suggests that SUDs are a continuous condition and that the severity level
increases as greater numbers of SUDs are present. In particular, IRT can evaluate how items
perform (e.g., item difficulty) along the underlying latent liability. IRT studies of DSM-IV
SUD criteria for individual SUD have found a unidimensional latent trait underlying
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diagnostic symptoms for each disorder (Gillespie et al., 2007; Langenbucher et al., 2004;
Saha et al., 2006; Wu et al., 2010a; Wu et al., 2009a Wu et al., 2009b).
These IRT studies focus mainly on an individual substance class. Because polysubstance use
is common among drug abusers, and the risk for addiction generally is accounted for by
shared, multiple familial and environmental factors (Kendler et al., 2003; Leri et al., 2003;
Rounsaville et al., 2003; Tsuang et al., 1998), it is likely that various SUDs indicate a
unifying dimensional severity trait (Kirisci et al., 2006). Very few studies have examined
polysubstance use as reflecting a single latent trait. Kirisci et al. (2002) examined lifetime
use of 10 substance classes and found that the 10 binary substance use variables were
scalable as an index for a continuous latent trait score, which was positively associated with
the level of other drug use-related problems. Kirisci et al. (2006) further applied IRT
analysis to examine dichotomous indicators (abuse/dependence versus no) of nine lifetime
SUDs (alcohol, cannabis, amphetamines, inhalants, hallucinogens, cocaine, opioids,
phencyclidine, sedatives) in a sample of family studies of SUDs. They found that various
binary variables of SUDs formed a unidimensional trait and that the trait score correlates
with risky sexual behavior and treatment use. These findings suggest the feasibility of
linking the latent factor score with other measures to better understand patients’ severity
profiles and inform nosological research (American Psychiatric Association [APA], 2010).
On the other hand, LCA can elucidate the presence of heterogeneity of poly-substance use or
disorders by using the information from response patterns of various SUDs to classify
individuals into a few mutually exclusive classes (Muthén and Muthén, 2000). For example,
Wu et al. (2009c) found three LCA-defined groups of ecstasy users distinguished by level of
drug use (primary marijuana, marijuana/cocaine, polysubstance); the most severe group was
most likely to use addiction treatment. Agrawal et al. (2006) performed LCA on 10 binary
indicators of lifetime drug use disorders and identified five groups (none, marijuana,
stimulants/hallucinogens, prescription drugs, pervasive polysubstance) that differed in other
psychiatric disorders. These results and others have shown that LCA-defined classes often
vary from less–to–more-severe profiles in family history and multiple health indicators,
suggesting LCA’s utility in distinguishing less from more severe groups to inform research
and differential intervention (e.g., Bucholz et al., 1996)
To date, studies often have focused on a single SUD and relied exclusively on either IRT or
LCA. Here, we consider all available SUDs and compare IRT and LCA results to evaluate
latent factor and class structures that may explain comorbid SUDs. While IRT analysis
provides empirical information on item-level functioning along the latent liability, LCA may
complement IRT results by differentiating less from more severe groups (heterogeneity).
The utility of IRT-defined latent poly-SUD score and LCA-defined poly-SUD groups then is
examined by regression procedures to assess their association with other standard
assessments of clinical severity, including the Addiction Severity Index (ASI), HIV Risk
Behavior Scale (HRBS), and SF-36 quality of life (Veilleux et al., 2010).
Due to high rates of comorbid SUDs in treatment-seeking patients and the need for
empirical data to inform treatment research and classification of SUDs, we examined a
geographically diverse sample of opioid-dependent adults to: (a) determine whether various
SUDs relate to a latent poly-SUD trait or latent groups (poly-SUD versus severe poly-SUD);
(b) identify demographic characteristics of opioid-dependent adults with increased odds of
poly-SUD to inform subgroup disparities; and, as suggested by the DSM-5 workgroup
(Saunders et al., 2007), (c) explore the utility of the latent poly-SUD by determining its
associations with subscales from ASI, HRBS, and SF-36. We extend from prior research by
examining study participants recruited from inpatient and outpatient addiction treatment
settings at 12 programs across the U.S., focusing on current SUDs and other clinical
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measures to better reflect clinical indicators of severity, including nicotine use disorders, and
using both continuous and categorical approaches to improve understanding of
heterogeneity among individuals with SUDs.
2. Methods
2.1. Data source
Analyses were performed on the data from two multisite Clinical Trials Network (CTN)
studies that evaluated the effectiveness of buprenorphine–naloxone and clonidine for opioid
detoxification in inpatient (N=113) and outpatient (N=230) community-based treatment
programs (Ling et al., 2005). Inpatients were recruited from six programs located in eastern,
southeastern, midwestern, or western regions of the U.S.; outpatients were recruited from six
programs located in eastern, midwestern, or western regions. Eligible patients included
adults aged ≥18 years who met DSM-IV criteria for opioid dependence and were in need of
medical management for opioid withdrawal.
Patients were excluded if they had a serious psychiatric/medical condition that would make
participation medically hazardous; had a known allergy or sensitivity to buprenorphine,
naloxone, or clonidine; were receiving medications contraindicated with clonidine or had a
systolic blood pressure <100 mm Hg or pulse <56 beats per minute; had been enrolled in a
methadone treatment program or had participated in another investigational drug study
within 30 days of study enrollment; or could not remain in the area for the duration of active
treatment. To enhance the study’s generalizability, dependence on other drugs did not
exclude individuals from participation unless immediate medical attention was required to
manage these disorders. Female participants were excluded if pregnant or lactating and were
required to have a negative pregnancy test prior to randomization.
2.2. Study variables
Demographics included age, gender, race/ethnicity, education, and employment status. Past-
year SUDs (abuse or dependence: tobacco/nicotine, alcohol, cannabis, cocaine, inhalants,
amphetamines/methamphetamine, sedatives, hallucinogens) were assessed by the DSM-IV
checklist (Hudziak et al., 1993). Substance-specific dependence criteria were assessed, and
endorsing ≥3 of the seven DSM-IV dependence criteria resulted in a dependence diagnosis
(tolerance, withdrawal, substance often taken in large amounts/for longer periods of time,
persistent desire or unsuccessful attempt to cut down, a great deal of time spent in activities
necessary to get the substance, important activities given up, continued substance use
despite knowledge of having recurrent physical/psychological problems). Substance-specific
abuse criteria were assessed, and endorsing ≥1 of the four DSM-IV abuse criteria resulted in
an abuse diagnosis (role interference, hazardous use, problems with the law, relationship
problems).
Addiction severity at intake was assessed by the ASI—a standardized clinical interview
widely used to assess substance use-related problems in alcohol use, drug use, medical,
psychiatric, legal, family/social, and employment domains (McGahan et al., 1982; McLellan
et al., 1985). Each ASI composite score (range 0–1) is mathematically derived to summarize
responses to several questions within a problem area, with higher scores indicating greater
problem severity.
HIV risk was assessed by the HRBS, an instrument with demonstrated reliability and
construct validity in drug users (Darke et al., 1991; Petry, 2001). It assesses injection drug
use (needle sharing, use of unclean needles) and unprotected sexual behaviors (multiple
sexual partners, lack of condom use) in the past 30 days. Responses to each item were coded
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on a six-point scale (0–5), with higher values associated with more risky behaviors. Three
summary scores were examined (total HIV risk, injection drug use risk, sexual risk).
Quality of life was assessed by the SF-36, a reliable and valid subject-administered
instrument (Ware and Sherbourne, 1992). It measures health-related quality of life in
physical functioning, role limitations due to physical health problems, role limitations due to
emotional problems, energy/vitality, emotional well-being, social functioning, bodily pain,
and general health perceptions. A higher score reflects better functioning.
2.3. Data analyses
Distributions of study variables were examined by descriptive analysis. Consistent with
studies on poly-SUDs that have examined dichotomous abuse/dependence variables
(Agrawal et al., 2006; Kirisci et al., 2006) and with findings showing that abuse and
dependence tap one factor (Gillespie et al., 2007; Langenbucher et al., 2004), we examined
six dichotomous variables (abuse/dependence versus no) for SUDs (nicotine, 41% of the
sample; cocaine, 28%; alcohol, 24%; cannabis, 17%; sedative, 6%; amphetamine, 5%) using
discrete factor, IRT, and LCA procedures (Mplus V5.1; Muthén and Muthén, 2007).
Hallucinogen (1.5%) and inhalant (0.3%) abuse/dependence were not included.
We conducted one-parameter and two-parameter IRT analyses because both have been
shown to describe the unidimensionality of abuse/dependence symptoms in different studies,
but little is known about their differences in SUD research (Gillespie et al., 2007; Kahler and
Strong, 2006; Langenbucher et al., 2004). The one-parameter model assumes that item
responses are a function of an individual’s overall level of SUD problems and severity
(threshold) of the items included. Item severity is defined by the location on a latent
continuum at which an item has a 50% likelihood of being present. An individual’s total
score is a summary of the responses to all items, making for simple summed score
sufficiency. In addition to item severity, the two-parameter model also allows item
discrimination to vary by SUD indicators, which measures the precision with which an
indicator differentiates between individuals with levels of the latent trait above or below its
severity level. In IRT, individuals with high levels of latent poly-SUD trait (scores) will
have a higher likelihood of having SUDs.
Non-nested models of IRT and LCA were compared by considering the number of
parameters, Bayesian information criterion (BIC), and sample-size adjusted BIC (ABIC)
(Muthén, 2006). BIC/ABIC takes into account parsimony of the model, with lower values
indicating a better model; they outperform Akaike information criterion in evaluating a fit to
observed responses (Nylund et al. 2007). For LCA models, we used Vuong-Lo-Mendell-
Rubin likelihood ratio (VLMR) tests to determine model differences, and entropy (1=perfect
delineation) to evaluate how well latent classes are distinguished (Lo et al., 2001). Both
provide information about the quality of LCA-defined classes.
To evaluate associations between empirically defined latent variables and other clinical
indicators, IRT-derived latent severity scores were regressed on demographics and clinical
severity (scores of subscales from ASI, HRBS, and SF-36) via multiple indicators–multiple
causes (MIMIC) modeling (Wu et al., 2010b; Wu et al., 2009a). MIMIC modeling
incorporates the latent poly-SUD score from all six SUDs into a regression model and
allows for statistical adjustment for variations in demographic covariates on the latent poly-
SUD score while simultaneously estimating associations of the latent poly-SUD score with
ASI, HRBS, and SF-36 variables. MIMIC modeling complements IRT analysis by providing
a means by which to link the latent poly-SUD score with clinical severity measures. To
elucidate clinical differences between LCA-defined classes, we conducted regression
analyses to determine associations of LCA-defined class membership (based on posterior
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probabilities) with subscales from ASI, HRBS, and SF-36. Both complement one another as
IRT describes the continuous distribution of poly-SUD, and LCA classifies groups based on
the pattern of poly-SUDs.
3. Results
3.1. Characteristics of opioid-dependent patients
Of the 343 opioid-dependent patients, 67% were outpatients, 68% were men, 55% were
nonwhites (31%, African Americans; 20%, Hispanics; 4%, others), and 49% were
employed. Table 1 summarizes descriptive results of ASI, HRBS, and quality-of-life
indicators.
3.2. Factor, IRT, and LCA analysis of SUDs
Factor analysis—An exploratory factor analysis of six dichotomous SUDs using
weighted least-squares approach suggested one factor (comparative fit index=1.0; 90%
confidence interval of root mean square error of approximation=0–0.06; weighted root mean
square residual=0.52) (Browne and Cudeck, 1993; Hu and Bentler, 1999). Factor loadings
for nicotine, cocaine, alcohol, cannabis, amphetamine, and sedative abuse/dependence were
0.41, 0.48, 0.57, 0.58, 0.85, and 0.61, respectively (reliability coefficient=0.76).
Model comparisons—Fit indices from IRT, LCA, and factor models (using MLR or
maximum likelihood parameter estimates) are summarized in Fig. 1. BIC (1842 vs. 1849)
indicated that a one-parameter model fit better than a two-parameter IRT model, while
ABIC (1823 vs. 1810) showed the opposite. Moreover, a two-class LCA model (with the
lowest BIC and ABIC) fit the data better than IRT and other LCA models. Among LCA
models, there were no differences in model fit between a two-class and a three-class model
(VLMR test, P=0.50) and between a three-class and a four-class model (VLMR test,
P=0.60). The two-class LCA model had a nearly perfect classification (entropy=0.99),
indicating a high quality of classification. As suggested by the two-class LCA model, a two-
factor model (nicotine/cocaine/alcohol/cannabis vs. amphetamines/sedatives; correlation of
the two factors=0.986) was conducted for comparison. The two-factor model also had a
larger BIC and ABIC than the two-class LCA model. Together, they indicated the two-class
LCA model as more parsimonious than other models.
LCA—Fig. 2 shows that Class 1 (90%) was distinct from Class 2 (10%) in having lower
rates of all SUDs: there were few between-class differences in nicotine abuse/dependence
(41% vs. 49%); notable differences in alcohol (21% vs. 49%), cannabis (15% vs. 39%), and
cocaine (25% vs. 58%) abuse/dependence; striking differences in amphetamine (0% vs.
55%) and sedative (0% vs. 61%) abuse/dependence.
One-parameter IRT model—Given that the one-parameter model (Fig. 3a) provides an
efficient means of summarizing all SUDs, translates them to an IRT score, and is more
parsimonious than a two-parameter model (eFig. 1, on-line only), we present the one-
parameter model results to complement LCA results. Of note, item characteristic curves
(Fig. 3a) and item information curves (Fig. 3b) from a one-parameter model were consistent
with a two-class LCA model by revealing that amphetamine and sedative abuse/dependence
tapped similarly severe levels of the latent poly-SUD trait (almost overlapping item
characteristic curves) than other disorders (cocaine/alcohol/cannabis, medium severity;
nicotine, low severity).
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3.3. Demographic predictors of the latent poly-SUD
Compared with individuals in Class 1 (Table 2), individuals in Class 2 were more likely to
be younger (mean age: 33 vs. 38), inpatients (52% vs. 31%), and white (82% vs. 41%). As a
comparison, we report MIMIC modeling of the latent poly-SUD factor score from the six
SUDs (one-parameter model), which showed that whites were more likely than African
Americans and Hispanics to have an increased level of poly-SUD trait.
3.4. Linking the latent poly-SUD with ASI, HRBS, and SF-36
Categorical LCA-defined groups—Table 3 shows that individuals in Class 2 were
more likely than individuals in Class 1 to have greater psychiatric problems and HIV risk
scores. Controlling for gender, age, race/ethnicity, education, employment, and treatment
setting, Class 2 still had a greater likelihood than Class 1 of having higher total HIV and
sexual risk scores; the association between class membership and psychiatric problems was
marginally significant (P=0.064).
Continuous IRT-defined latent poly-SUD trait—Table 4 display associations between
the latent poly-SUD score and subscales of ASI, HRBS, and SF-36 while controlling for
treatment setting, gender, age, race/ethnicity, education, and employment status. Greater
severity of ASI alcohol, drug use, and psychiatric problems and of total HIV risk were
positively associated with increased levels of poly-SUD; three areas of quality of life were
negatively associated with poly-SUD, indicating that a better functioning in physical health,
bodily pain, and general health were associated with a decreased level of poly-SUD. As a
check, we compared these results of MIMIC modeling of latent poly-SUD score based on
the one-parameter model with results of MIMIC modeling of latent poly-SUD score based
on a two-parameter model (data not shown). All significant associations from the former
were found in the latter analysis; the latter also showed that physical functioning, energy,
and emotional well-being were negatively associated with levels of poly-SUD.
4. Discussion
4.1. Main findings
Comorbid SUDs are a widespread problem among patients with opioid addiction, but little is
known about how to use total diagnostic configurations to improve research on SUDs. One
unique advantage of latent variable approaches is their use of fuller information from diverse
patterns of all available SUDs and their translation into fewer meaningful groups (LCA) or a
single interval IRT-based scale. Results suggest that a combined application of both
categorical (LCA) and dimensional (IRT) approaches can improve understanding of
comorbid SUDs and their associations with clinically important indicators. LCA elucidates
heterogeneity of poly-SUD by distinguishing 10% of severe comorbid opioid-dependent
individuals with high rates of all SUDs (especially amphetamine and sedative abuse/
dependence) from the 90% with SUDs other than amphetamine and sedative abuse/
dependence. Although IRT conceptualizes SUD problems as a continuous trait, item-level
results from one-parameter and two-parameter models also found that amphetamine and
sedative abuse/dependence (almost overlapping item characteristic curves) tapped the
severe-to-most-severe end of the latent poly-SUD trait. Therefore, assuming that the one-
parameter IRT model’s assumption is feasible, individuals who had amphetamine or
sedative abuse/dependence also had higher rates of other SUDs examined than those without
amphetamine and sedative abuse/dependence. This finding was clearly observed from LCA
results (Fig. 2).
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4.2. What this study adds
Notably, these results suggest the complexity and limitations of conclusions drawn
exclusively from either a categorical or a dimensional approach as the study constructs are
constrained by each model. Specifically, LCA and IRT are important tools in research on
SUDs due to needs for empirical data to inform revisions for DSM-5 and to incorporate
dimensional measures to enhance the categorical DSM system (APA, 2010). However,
reliance on either a categorical or dimensional approach exclusively may result in a narrow
view of the findings. For example, the unidimensional IRT model does not generate
categories of individuals, which are critical to clinical decision-making and ease of
communication (APA, 2000). On the other hand, the categorical LCA approach could
address this limitation by providing categories of individuals to help evaluate IRT results.
As shown from findings, LCA pinpoints 10% of individuals with severe poly-SUDs who are
clearly distinct from the other 90% in having higher rates of all SUDs, especially
amphetamine (55% vs. 0%) and sedative (61% vs. 0%) abuse/dependence. Two LCA-
defined groups are almost perfectly classified (entropy=0.99). Markedly, item-level
estimates from one- and two-parameter IRT models support this finding that individuals
with amphetamine or sedative abuse/dependence had higher liabilities of exhibiting other
SUDs than those without. Thus, combined use of LCA and IRT analyses may enhance
research findings.
The finding that a LCA model fit to the SUD data empirically better than IRT models has
implications for research and intervention. Similar studies have examined lifetime SUDs and
used either LCA (Agrawal et al., 2006) or IRT methods (Kirisci et al., 2006). LCA research
has shown that individuals with SUDs can be classified into a few subgroups distinct in the
severity of SUDs and other psychiatric problems (Agrawal et al., 2006); IRT research has
demonstrated that multiple SUDs form a unidimensional trait and that its score correlates
with risky sexual behavior and treatment use (Kirisci et al., 2006). This study examined
current SUDs and compared both approaches to comorbid SUDs. The two-class model
indicates a high quality of classification. Importantly, LCA reveals that younger, white
opioid-dependent individuals were disproportionally affected by SUDs (especially cocaine,
amphetamines, sedatives), and this severe group had elevated levels of psychiatric problems
and HIV risk, a finding that enhances understanding of elevated HIV risk and
psychopathology among white opioid-dependent individuals and helps specify high-risk
groups for focused interventions (Wu et al., 2010c). For instance, amphetamines/
methamphetamine appear to replace cocaine as the drug most associated with HIV risk
behaviors in the U.S. (Rondinelli et al., 2009). Methamphetamine users also report more
serious patterns of substance use and psychopathology than cocaine users (Copeland and
Sorensen, 2001; Leamon et al., 2002). Similarly, among methadone maintenance patients,
sedative/benzodiazepine use was associated with elevated rates of polysubstance use and
psychopathology (Brands et al., 2008; Drake et al., 1993). Together, abuse of sedatives or
amphetamines may serve to identify severe subsets of opioid-dependent individuals needing
more intensive interventions.
Finally, this study extends IRT studies by examining both one- and two-parameter models
and by demonstrating an innovative means of modeling SUDs simultaneously by
transforming them into a single interval IRT-based scale linked with clinical indicators in
MIMIC modeling. Both one- and two-parameter models showed that co-existing SUDs form
a unifying unidimensional trait, ranging from less to more severe as various comorbid SUDs
are present. This continuous construct is supported by MIMIC modeling in that severity of
poly-SUD (factor score) was positively associated with greater alcohol/drug and psychiatric
problems and with poorer health-related quality of life. These findings are consistent with
others showing that drug abusers use multiple substances to enhance, moderate, or alleviate
subjective psychoactive effects of drug use, and that repeated drug consumption further
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escalates users’ risk for severe addiction and health problems (Koob, 2006; Leri et al.,
2003).
4.3. Limitations and strengths
This study has limitations. The sample is not necessarily representative of all opioid-
dependent patients. The data rely on self-reports that are subject to recall or reporting bias.
Nonetheless, studies have found that self-reported drug use, injecting behaviors, and risky
sexual behaviors among problematic drug users are generally reliable (Darke, 1998;
McElrath et al., 1994; Goldstein et al., 1995; Petry, 2001). This study also is limited by
sample size (N=343). LCA requires a larger sample than IRT analysis to derive categories.
The current sample size might contribute to the findings that regression analyses for LCA-
defined groups found fewer significant associations than those for an IRT-defined
continuous variable. Like prior research on comorbid SUDs, this study is constrained by use
of diagnostic-level abuse/dependence indicators for the analysis (Agrawal et al., 2006;
Kirisci et al., 2006). Ideally, all symptom-level items across all drugs should be analyzed
simultaneously; however, no research paradigm addresses the complexity of modeling a
very large number of items. Lastly, there are other more complex hybrid explanations of
data (factor mixture model) that may be worthy of research.
4.4. Conclusions
Findings suggest that, regardless of whether SUDs were defined as a continuous trait or
categories, individuals characterized by a high level of poly-SUD had elevated levels of
psychiatric problems and HIV risk behaviors indicating differential intervention needs. The
LCA approach provides practically useful information for informing more focused
interventions by pinpointing specific groups with severe comorbid SUDs; the IRT
conceptualization of SUDs as a continuous condition is heuristically consistent with the
nature of a medical disorder, and as such, emphasizes screening and early prevention for
managing a chronic addiction to avoid more costly consequences. Overall, these approaches
appear to complement one another and support the recommendation to target multiple SUDs
rather than a single SUD in addiction treatment and research (Rounsaville et al., 2003).
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Comparisons of Bayesian information criterion (BIC) and sample-size adjusted BIC (ABIC)
from item response theory (IRT), factor analysis, and latent class analysis (LCA) models for
DSM-IV substance use disorders among adult patients in opiate detoxification treatment
(N=343).
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A latent class analysis of DSM-IV substance use disorders among adult patients in opiate
detoxification treatment (N=343).
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Fig. 3a. The latent poly-substance use disorder syndrome among adult patients in opiate
detoxification treatment (N=343): a one-parameter item response theory model. Note:
Severity parameters for each disorder: nicotine, 0.30; cocaine, 0.78; alcohol, 0.97; cannabis,
1.30; sedative, 2.17; amphetamine, 2.25.
Fig. 3b. The latent poly-substance use disorder syndrome among adult patients in opiate
detoxification treatment (N=343): item and total information curves in a one-parameter item
response theory model.
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Table 1
Selected characteristics of adult patients in opiate addiction treatment (N=343)
Characteristics
Treatment setting, %
 Inpatient opiate detoxification 32.94
 Outpatient opiate detoxification 67.06
Age in years










 Mean (SD) 12.62 (2.06)
Past-month employment, %
 Employed/working 49.27
 Unemployed/not employed 50.73
ASI subscales, mean (SE)
 Alcohol problems 0.07 (0.01)
 Drug use problems 0.33 (0.01)
 Employment problems 0.56 (0.02)
 Family/social problems 0.08 (0.01)
 Legal problems 0.15 (0.01)
 Medical problems 0.15 (0.02)
 Psychiatric problems 0.21 (0.01)
HRBS subscales, mean (SE)
 Total HIV risk score 12.21 (0.49)
 Injecting drug use risk score 6.91 (0.35)
 Sexual risk score 5.29 (0.31)
SF-36 subscale scores, mean (SE)
 Physical functioning 83.20 (1.19)
 Role limitations due to physical health 57.94 (2.32)
 Role limitations due to emotional problems 54.10 (2.43)
 Energy/fatigue/vitality 44.60 (1.17)
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Characteristics
 Emotional well-being 55.36 (1.15)
 Social functioning 59.74 (1.52)
 Bodily pain 63.81 (1.50)
 General health 59.07 (1.13)
SD: standard deviation; SE: standard error.
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Table 2
Demographic characteristics of the low versus high poly-substance use disorder groups among adult patients
in opiate detoxification treatment (N=343)
Latent class membership C1: Low severity C2: High severity χ2 (df) or t-test Crude regression coefficient, β1
Sample size N= 310 N=33 N=343
Age in years
 Mean (SE) 37.99 (0.57) 32.97 (1.72) t=2.77** −0.01 NS
Education in years
 Mean (SE) 12.61 (0.12) 12.73 (0.34) t=0.32 NS 0.06 NS
Treatment setting, %
 Inpatient 31.0 51.5 5.70 (1)* 0.13 NS
 Outpatient 69.0 48.5 1.00
Gender, %
 Male 68.1 66.7 0.03 (1) 0.01 NS
 Female 31.9 33.3 NS 1.00
Race/ethnicity,%
 White 41.3 81.8 19.78 (1)** ----
 Non-white 58.7 18.2 ----
Race/ethnicity,%
 White 41.3 81.8 22.67 (3)** 1.00
 African American 34.2 0 −0.25*
 Hispanic 20.6 15.2 −0.45**
 Other 3.9 3.0 −0.35 NS
Employment,%
 Employed 51.3 45.5 0.41 (1) −0.07 NS
 Not employed 48.7 54.5 NS 1.00
1
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Table 3
Regression analysis of ASI, HIV risk, and quality of life in relation to the poly-substance use disorder status
among adult patients in opiate detoxification treatment (N=343)
Latent class membership C2 vs. C1: Severe poly-SUD vs. poly-SUD C2 vs. C1: Severe poly-SUD vs. poly-SUD
Standardized regression coefficient (β) Crude β1 Adjusted β2
ASI subscales
 Alcohol problems 0.05 0.10
 Drug use problems 0.09 0.07
 Employment problems −0.07 0.01
 Family/social problems 0.08 0.02
 Legal problems 0.05 0.04
 Medical problems 0.06 0.06
 Psychiatric problems 0.14** 0.10†
HRBS subscales
 Total HIV risk score 0.15*** 0.10*
 Injecting drug use risk score 0.11* 0.05
 Sexual risk score 0.12* 0.14*
SF-36 subscales
 Physical functioning −0.08 0.07
 Role limitations due to physical health −0.09 −0.01
 Role limitations due to emotional problems −0.02 0.003
 Energy/fatigue/vitality −0.05 0.003
 Emotional well-being −0.04 −0.01
 Social functioning −0.02 −0.01
 Bodily pain −0.03 −0.01










The unadjusted linear regression model included one variable listed in that row.
2
The adjusted model included class membership variable, gender, age, race/ethnicity, education, employment, and treatment setting.
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Table 4
The MIMIC modeling of the poly-substance use disorder syndrome and its association with ASI, HIV risk,
and quality of life among adult patients in opiate detoxification treatment (N=343)
The MIMIC model of the latent factor score of the six substance use disorders:
regression coefficient (β) Standardized crude β1 Standardized adjusted β2
ASI subscales
 Alcohol problems 0.40*** 0.46***
 Drug use problems 0.51*** 0.50***
 Employment problems −0.001 −0.01
 Family/social problems 0.17* 0.15
 Legal problems 0.14 0.12
 Medical problems 0.12 0.11
 Psychiatric problems 0.26*** 0.27***
HRBS subscales
 Total HIV risk score 0.18* 0.18*
 Injecting drug use risk score 0.13 0.11
 Sexual risk score 0.08 0.11
SF-36 subscales
 Physical functioning −0.10* −0.10†
 Role limitations due to physical health −0.22** −0.22**
 Role limitations due to emotional problems −0.12 −0.15
 Energy/fatigue/vitality −0.10 −0.08
 Emotional well-being −0.12 −0.09
 Social functioning −0.08 −0.07
 Bodily pain −0.22*** −0.21**










The unadjusted model included one variable listed in that row.
2
The adjusted model included one variable listed in that row, adjusting for gender, age, race/ethnicity, education, employment, and treatment
setting.
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